Cirrus Pharmaceuticals
Cirrus Pharmaceuticals is a private, for-profit pharmaceutical services company founded in 1997, based in Morrisville, United States, with 51-100 employees providing full product development and task-based services to clients.
- Company typePrivate
- Founded1997
- HeadquartersMorrisville, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Cirrus Pharmaceuticals does
Cirrus Pharmaceuticals is a private, for-profit pharmaceutical services company headquartered in Morrisville, United States, founded in 1997 and employing between 51 and 100 people. According to the firmographic short description, the company "provides full product development as well as task-based services," which is consistent with a contract development or services business that supports clients across the pharmaceutical product lifecycle, offering both end-to-end development programs and discrete, project-based engagements.
The substantive source content available is highly limited: the only external web data point is a HugeDomains.com marketplace listing showing that the company's web domain, CirrusPharm.com, is currently for sale for $6,695. No revenue, funding, ownership, management, customer, product detail, partnership, certification, or technology information is present in the provided inputs. This represents a significant data gap. The domain lapse raises a question about the company's current operating posture and should be confirmed through primary-source verification before any operational or transactional conclusions are drawn.
Cirrus Pharmaceuticals firmographics
Firmographics- Name
- Cirrus Pharmaceuticals
- Website
- https://cirruspharm.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Cirrus Pharmaceuticals is a private, for-profit pharmaceutical services company founded in 1997, based in Morrisville, United States, with 51-100 employees providing full product development and task-based services to clients.
- Ownership category
- akta.pro rank
Cirrus Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Development Services
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industries
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
Keywords
Where Cirrus Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Morrisville
- HQ country
- United States
- HQ region
- North America
Markets served
Cirrus Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Cirrus Pharmaceuticals product offering
Product offeringCore offering
Cirrus Pharmaceuticals provides full product development as well as task-based pharmaceutical services. The company supports clients across the pharmaceutical development lifecycle, offering both end-to-end development programs and modular, task-based service engagements. Founded in 1997 and based in Morrisville, United States, the company operates with 51-100 employees.
Differentiator
Problem solved
Functional benefit
Products and services
- Full Pharmaceutical Product Development End-to-end pharmaceutical product development services for client organizations needing comprehensive development support across the development lifecycle.
- Task-Based Pharmaceutical Services Modular, task-based pharmaceutical services for clients requiring specific, discrete development activities rather than a full development program.
Companies that use Cirrus Pharmaceuticals
Customer profileIdeal customer profiles1 record
Cirrus Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Cirrus Pharmaceuticals partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights2 records
Cirrus Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Alcami Corporation: North Carolina–headquartered CDMO offering formulation development, analytical services, and small-molecule manufacturing. Most directly comparable peer given overlapping geography, service mix, and mid-tier scale.
- Cambrex: Mid-sized CDMO focused on small-molecule API development, analytical services, and finished dosage forms. Closely aligned to Cirrus's likely full product development and task-based service model.
- Aptuit (Evotec): Pharmaceutical services provider offering integrated CMC, formulation, and analytical development for small molecules. Highly comparable service model with similar mid-tier positioning.
- Recipharm: European-headquartered CDMO providing development, scale-up, and manufacturing services for small molecules. Comparable in offering scope though primarily serving European sponsors.
- SGS Life Sciences: Contract analytical, bioanalytical, and clinical research services provider serving pharma and biopharma. Comparable in task-based testing and development services adjacent to Cirrus's likely portfolio.
- AMRI (Curia): Contract development and manufacturing organization providing API synthesis, formulation, and analytical services. Comparable in mid-tier CDMO positioning and small-molecule focus.
Broad incumbents
- Patheon (Thermo Fisher Pharma Services): Global CDMO offering full-spectrum pharmaceutical development, scale-up, and commercial manufacturing. Comparable in service scope; materially larger and part of a diversified life-sciences platform.
- Catalent: Large global CDMO providing formulation, softgel, biologics, and clinical supply services. Overlaps Cirrus's development and manufacturing service lines but at a far larger scale.
- WuXi STA (WuXi AppTec): Global CRO/CDMO platform covering drug discovery, development, and commercial manufacturing. Comparable in service breadth but operates at substantially greater scale and geographic reach.
- Eurofins CDMO: Diversified contract services group offering pharmaceutical development, analytical, and manufacturing capabilities through multiple subsidiaries. Comparable in breadth but operates as part of a much larger testing/services conglomerate.
Market position
Strengths4 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
Cirrus Pharmaceuticals social profiles
Digital presenceCirrus Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cirrus Pharmaceuticals leadership team
Management profileNumber of profiles
Cirrus Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cirrus Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cirrus Pharmaceuticals
What does Cirrus Pharmaceuticals do?
Cirrus Pharmaceuticals provides full product development as well as task-based pharmaceutical services. The company supports clients across the pharmaceutical development lifecycle, offering both end-to-end development programs and modular, task-based service engagements. Founded in 1997 and based in Morrisville, United States, the company operates with 51-100 employees.
When was Cirrus Pharmaceuticals founded?
Cirrus Pharmaceuticals was founded in 1997. It employs 51 to 100 people.
Where is Cirrus Pharmaceuticals based?
Cirrus Pharmaceuticals is headquartered in Morrisville, United States, in the North America region.
Who are Cirrus Pharmaceuticals's main competitors?
Direct peers on record are Alcami Corporation, Cambrex, Aptuit (Evotec), Recipharm, SGS Life Sciences and AMRI (Curia). Broad incumbents are Patheon (Thermo Fisher Pharma Services), Catalent, WuXi STA (WuXi AppTec) and Eurofins CDMO.
Does Cirrus Pharmaceuticals have an API?
No public API is recorded for Cirrus Pharmaceuticals.
What industry is Cirrus Pharmaceuticals in?
Cirrus Pharmaceuticals's product category is Pharmaceutical Development Services. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 32541 and its SIC code is 2834.